Stock Research: Apollo Hospitals Enterprise

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Apollo Hospitals Enterprise

NSEI:APOLLOHOSP INE437A01024
33
  • Value
    16
  • Growth
    71
  • Safety
    Safety
    16
  • Combined
    8
  • Sentiment
    80
  • 360° View
    360° View
    33
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Apollo Hospitals Enterprise Limited is an integrated healthcare company providing hospital services, pharmacy sales, and wellness products. It operates in Healthcare Services, Retail Health and Diagnostics (clinics and diagnostics), Digital Health and Pharmacy Distribution (pharmaceuticals, FMCG, private label products via digital platform), and Others. The company has approximately 10,000+ beds across 73 hospitals, 5000+ pharmacies, 378+ clinics and diagnostic centers, and 200 telemedicine centers. In the last fiscal year, the company had a market cap of $12298 million, profits of $1227 million, and revenue of $2550 million.

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
16 17 8 11
Growth
71 91 87 95
Safety
Safety
16 14 24 12
Sentiment
80 55 82 59
360° View
360° View
33 31 48 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
93 81 82 87
Opinions Change
48 33 54 50
Pro Holdings
n/a 32 42 12
Market Pulse
83 84 74 55
Sentiment
80 55 82 59
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
16 17 8 11
Growth
71 91 87 95
Safety Safety
16 14 24 12
Combined
8 20 23 16
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
11 13 5 7
Price vs. Earnings (P/E)
49 39 42 36
Price vs. Book (P/B)
9 5 5 9
Dividend Yield
25 28 24 25
Value
16 17 8 11
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
94 83 87 70
Profit Growth
82 73 61 98
Capital Growth
23 93 98 36
Stock Returns
43 41 51 97
Growth
71 91 87 95
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
16 20 28 14
Refinancing
27 17 21 25
Liquidity
39 51 46 25
Safety Safety
16 14 24 12

Similar Stocks

Discover high‑ranked alternatives to Apollo Hospitals Enterprise and broaden your portfolio horizons.

Cipla

NSEI:CIPLA
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Fleury

BOVESPA:FLRY3
Country: Brazil
Industry: Health Care Services
Size: Medium
Full Stock Analysis

Maruti Suzuki

NSEI:MARUTI
Country: India
Industry: Automobile Manufacturers
Size: Large
Full Stock Analysis

Bosch

BSE:500530
Country: India
Industry: Auto Parts & Equipment
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This is a classic, high-risk growth play: high growth and positive sentiment outweigh low Value Rank (expensive) and risky financing. This is for aggressive growth investors who are comfortable with the high price and risk, believing the growth story justifies the expense.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: